Answers are grounded in this paper and cite their sources.
ALS is associated with a defect in high-affinity glutamate transport that has disease, region, and chemical specificity. Defects in the clearance of extracellular glutamate because of a faulty transporter could lead to neurotoxic levels of extracellular glutamate and thus be pathogenic in ALS.
No takes yet. Share an insight, caveat, or question.
Rothstein et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: